The forecasted number of clinically diagnosed relapse pulmonary tuberculosis cases in Japan indicates a declining trend from 2024 to 2028. Starting at 58 cases in 2024, it drops to 45 cases by 2028. This reflects a consistent downward trend, with the number of cases reducing year-on-year. In 2023, actual data is not provided, but forecasted data in subsequent years suggest progressive reductions. The compound annual growth rate (CAGR) over these five years highlights a consistent decrease in relapse cases.
Future trends to watch for include monitoring new treatment protocols, public health initiatives, and changes in healthcare access that may further impact the prevalence and management of tuberculosis in Japan. Additionally, attention to global tuberculosis trends and their influence on Japan could offer deeper insights into managing relapse cases effectively.
